TTY Biopharm Company Limited (TPEX:4105)
Taiwan
· Delayed Price · Currency is TWD 77.00
+1.10 (1.45%)
Jun 6, 2025, 1:30 PM CST
TTY Biopharm Company Balance Sheet
Financials in millions TWD. Fiscal year is January - December.
Millions TWD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2015 - 2019 |
|---|---|---|---|---|---|---|---|
Period Ending | Mar '25 Mar 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2015 - 2019 |
| Cash & Equivalents | 2,848 | 2,773 | 2,621 | 2,357 | 2,222 | 2,224 | Upgrade
|
| Short-Term Investments | 386.84 | 309.02 | 195.54 | 326.86 | 372.65 | 342.4 | Upgrade
|
| Cash & Short-Term Investments | 3,234 | 3,082 | 2,817 | 2,684 | 2,595 | 2,566 | Upgrade
|
| Cash Growth | 3.08% | 9.41% | 4.93% | 3.44% | 1.12% | -11.66% | Upgrade
|
| Accounts Receivable | 1,272 | 1,354 | 1,344 | 1,227 | 1,138 | 1,033 | Upgrade
|
| Other Receivables | 55.99 | 23.18 | 28.81 | 29.68 | 13.62 | 16.48 | Upgrade
|
| Receivables | 1,328 | 1,377 | 1,373 | 1,257 | 1,151 | 1,050 | Upgrade
|
| Inventory | 1,209 | 1,270 | 1,096 | 1,039 | 955.01 | 1,111 | Upgrade
|
| Prepaid Expenses | 70.68 | 57.91 | 79.02 | 49.89 | 46.96 | 64.15 | Upgrade
|
| Other Current Assets | 22.66 | 6.67 | 6.36 | 5.37 | 1.15 | 8.01 | Upgrade
|
| Total Current Assets | 5,865 | 5,793 | 5,370 | 5,035 | 4,749 | 4,799 | Upgrade
|
| Property, Plant & Equipment | 2,214 | 2,246 | 2,287 | 2,433 | 2,519 | 2,585 | Upgrade
|
| Long-Term Investments | 1,977 | 1,945 | 1,578 | 1,496 | 1,432 | 1,458 | Upgrade
|
| Goodwill | 247.9 | 247.9 | - | - | - | - | Upgrade
|
| Other Intangible Assets | 186.08 | 123.44 | 164.01 | 250.75 | 124.9 | 132.9 | Upgrade
|
| Long-Term Deferred Tax Assets | 58.53 | 58.52 | 48.71 | 47.1 | 63.72 | 61.8 | Upgrade
|
| Other Long-Term Assets | 424.47 | 448.25 | 426.94 | 337.89 | 407.19 | 324.72 | Upgrade
|
| Total Assets | 10,973 | 10,863 | 9,875 | 9,601 | 9,296 | 9,361 | Upgrade
|
| Accounts Payable | 163.76 | 326.16 | 294.66 | 289.4 | 187.27 | 159.44 | Upgrade
|
| Short-Term Debt | 1,000 | 1,200 | 1,450 | 1,370 | 1,711 | 1,715 | Upgrade
|
| Current Portion of Long-Term Debt | 400 | 400 | - | 418.85 | 407.91 | 16.54 | Upgrade
|
| Current Portion of Leases | 2.29 | 0.93 | 5.86 | 3.92 | 7.62 | - | Upgrade
|
| Current Income Taxes Payable | 336.32 | 228.8 | 156.97 | 149.52 | 150.39 | 110.13 | Upgrade
|
| Current Unearned Revenue | 35.52 | 34.34 | 14.23 | 33.13 | 39.77 | 16.29 | Upgrade
|
| Other Current Liabilities | 1,658 | 672.18 | 662.02 | 652.62 | 547.55 | 531.2 | Upgrade
|
| Total Current Liabilities | 3,596 | 2,862 | 2,584 | 2,917 | 3,052 | 2,549 | Upgrade
|
| Long-Term Debt | 100 | 100 | 400 | 9.6 | 4.15 | 412.05 | Upgrade
|
| Long-Term Leases | 9.47 | 10.2 | 3.05 | 3.04 | 14.16 | - | Upgrade
|
| Long-Term Deferred Tax Liabilities | 359.24 | 359.24 | 318.75 | 305.44 | 260.52 | 271.83 | Upgrade
|
| Other Long-Term Liabilities | 2.44 | 2.44 | 35.83 | 91.03 | 146.23 | 4.7 | Upgrade
|
| Total Liabilities | 4,085 | 3,352 | 3,369 | 3,367 | 3,529 | 3,283 | Upgrade
|
| Common Stock | 2,487 | 2,487 | 2,487 | 2,487 | 2,487 | 2,487 | Upgrade
|
| Additional Paid-In Capital | 317.18 | 317.04 | 316.62 | 312.18 | 311.88 | 338 | Upgrade
|
| Retained Earnings | 3,235 | 3,888 | 3,182 | 2,925 | 2,568 | 2,759 | Upgrade
|
| Comprehensive Income & Other | 79.56 | 58.69 | -43.79 | -64.78 | -198.07 | -133.71 | Upgrade
|
| Total Common Equity | 6,118 | 6,750 | 5,941 | 5,658 | 5,168 | 5,450 | Upgrade
|
| Minority Interest | 769.83 | 760.49 | 564.8 | 574.86 | 599.38 | 628.3 | Upgrade
|
| Shareholders' Equity | 6,888 | 7,511 | 6,506 | 6,233 | 5,767 | 6,078 | Upgrade
|
| Total Liabilities & Equity | 10,973 | 10,863 | 9,875 | 9,601 | 9,296 | 9,361 | Upgrade
|
| Total Debt | 1,512 | 1,711 | 1,859 | 1,805 | 2,145 | 2,144 | Upgrade
|
| Net Cash (Debt) | 1,723 | 1,371 | 957.65 | 878.78 | 450 | 422.47 | Upgrade
|
| Net Cash Growth | 16.38% | 43.11% | 8.97% | 95.28% | 6.52% | -56.51% | Upgrade
|
| Net Cash Per Share | 6.91 | 5.50 | 3.84 | 3.53 | 1.81 | 1.70 | Upgrade
|
| Filing Date Shares Outstanding | 248.65 | 248.65 | 248.65 | 248.65 | 248.65 | 248.65 | Upgrade
|
| Total Common Shares Outstanding | 248.65 | 248.65 | 248.65 | 248.65 | 248.65 | 248.65 | Upgrade
|
| Working Capital | 2,269 | 2,931 | 2,787 | 2,118 | 1,698 | 2,250 | Upgrade
|
| Book Value Per Share | 24.61 | 27.15 | 23.89 | 22.76 | 20.78 | 21.92 | Upgrade
|
| Tangible Book Value | 5,684 | 6,379 | 5,777 | 5,408 | 5,043 | 5,317 | Upgrade
|
| Tangible Book Value Per Share | 22.86 | 25.65 | 23.23 | 21.75 | 20.28 | 21.38 | Upgrade
|
| Land | 902.9 | 902.9 | 902.9 | 902.9 | 902.9 | 902.9 | Upgrade
|
| Buildings | 1,479 | 1,479 | 1,461 | 1,432 | 1,420 | 1,311 | Upgrade
|
| Machinery | 1,433 | 1,446 | 1,432 | 1,418 | 1,359 | 1,234 | Upgrade
|
| Construction In Progress | 0.78 | 0.59 | 8.95 | 77.09 | 95 | 323.33 | Upgrade
|
Updated Feb 26, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.